Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase

British Journal of Cancer

Volumn 84, Issue 12, 2001, Pages 1677-1680

  Cuq, P ^a,b   Rouquet, C ^a   Evrard, A ^a   Ciccolini, J ^b   Vian, L ^a   Cano, J P ^a  

^a UNIV MONTPELLIER   (France)

^b Lab de Toxicocinetique et P   (France)

Author keywords

5 DFUR; 5 FU; Breast cancer; Cancer gene therapy; Uridine phosphorylase

Indexed keywords

FLUOROPYRIMIDINE; FLUOROURACIL; URIDINE PHOSPHORYLASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; FEMALE; FLUOROURACIL; GENE THERAPY; HUMANS; RIBONUCLEOTIDES; TRANSFECTION; TUMOR CELLS, CULTURED; URIDINE PHOSPHORYLASE;

EID: 0035875466     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1833     Document Type: Article

References (20)

1. Thymidine phosphorylase: Its role in sensitivity and resistance to anticancer drugs
2. Metabolism and biological activity of 5′-deoxy-5-fluorouridine, a novel fluoropyrimidine
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding
4. Enhanced antitumor activity of 5-fluorouracil in combination with 2′-deoxinosine in human colorectal cell lines and human colon tumor xenografts
5. An in vitro nucleoside analog screening method for cancer gene therapy
6. Enhancement of 5-fluorouracil cytotoxicity by human thymidine phosphorylase expression in cancer cells: In vitro and in vivo study
7. Increased cytotoxicity and bystander effect of 5′-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
8. Sensitivity of human KB cells expressing platelet-derived endithelial cell growth factor factor to pyrimidine antimetabolites
9. Augmentation of antitumor activity of 5′-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo
10. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine
11. Enhancement of the anti-tumor effect of 5′-deoxy-5-fluorouridine by transfection of thymidine phosphorylase gene into human colon cancer cells
12. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA
13. Prediction of response to 5′-deoxy-5-fluorouridine (5′-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor
14. 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity
15. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-desoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase
16. Sensitivity of human, murine, and rat cells to 5-fluorourcil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes
17. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil' derivatives in advanced gastric carcinoma
18. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil
19. Cloning and expression of human uridine phosphorylase
20. Purification, cloning, and expression of uridine phosphorylase